Lymphoma: all 5,624 studies
Page 49 of 57. Open to participants first (824), then studies with results posted, then the rest; newest registration first within each.
- AMG 706 and Gemcitabine in Treating Patients With Advanced Solid Tumors or LymphomaStatus unknownNCT00324597Phase 1
- Tailoring Treatment for B Cell Non-hodgkin's Lymphoma Based on PET Scan Results Mid TreatmentStatus unknownNCT00324467Phase 2
- Moxifloxacin in Preventing Bacterial Infections in Patients Who Have Undergone Donor Stem Cell TransplantTerminatedNCT00324324Phase 3
- Study of MGCD0103 Given Three-Times Weekly in Patients With Advanced Solid Tumors or Non-Hodgkin's LymphomaCompletedNCT00323934Phase 1
- CHOP and Campath-1H in Previously Untreated Aggressive T/NK-Cell LymphomasCompletedNCT00323323Phase 1
- A Phase II Clinical Trial of Lenalidomide for T-cell Non-Hodgkin's LymphomaCompletedNCT00322985Phase 2
- Study of the Vascular Disrupting Agent NPI-2358 in Patients With Advanced Solid Tumors or LymphomaCompletedNCT00322608Phase 1
- CDDO to Treat Solid Tumors and LymphomasCompletedNCT00322140Phase 1
- Study of CS-1008 in Patients With Advanced Solid Malignancies and Lymphomas (Without Leukemic Component)CompletedNCT00320827Phase 1
- A Comparative Study Of Iodine I 131 Tositumomab Therapeutic Regimen Versus Ibritumomab Tiuxetan Therapeutic RegimenWithdrawnNCT00319332Phase 3
- Total-Body Irradiation and Cyclophosphamide in Treating Patients Who Are Undergoing Donor Stem Cell Transplant for Hematologic Cancer and Other DiseasesCompletedNCT00317785Phase 2
- Combination Chemotherapy Followed By Stem Cell Transplant in Treating Young Patients With Progressive or Relapsed Anaplastic Large Cell LymphomaStatus unknownNCT00317408Not applicable
- FCM Versus R-FCM Followed by R-Maintenance or Observation OnlyStatus unknownNCT00317096Phase 3
- Study of L-NDDP (Aroplatin) in Patients With Advanced Solid Malignancies or B-Cell LymphomaCompletedNCT00316511Phase 1
- Sodium Stibogluconate and Interferon in Treating Patients With Advanced Solid Tumors, Lymphoma, or MyelomaTerminatedNCT00311558Phase 1
- Efficacy and Safety Study of SH T 586 in Combination With Rituximab to Treat Low-Grade NHLCompletedNCT00311129Phase 2
- Low-Dose Radiation Therapy in Treating Patients With Follicular or Marginal Zone Non-Hodgkin's LymphomaCompletedNCT00310167Phase 3
- Combination Chemotherapy Followed by Rituximab and Yttrium Y 90 Ibritumomab Tiuxetan in Treating Patients With Relapsed or Refractory AIDS-Related Non-Hodgkin's LymphomaWithdrawnNCT00310128Phase 2
- Influenza Vaccination in Patients Receiving Antineoplastic Therapy for Non-Hodgkin's LymphomaCompletedNCT00307710Phase 2
- Trivalent Baculovirus-expressed Influenza HA Vaccine in Adults With Non-Hodgkin's B-cell LymphomaCompletedNCT00307177Phase 2
- Study of Oral Bexarotene in Combination With Photopheresis for Treatment of Cutaneous T-Cell LymphomaCompletedNCT00306969Phase 1/2
- Pegfilgrastim vs. Filgrastim - Comparison of Mobilized Blood Stem Cells in Patients With Non Hodgkin-lymphomaCompletedNCT00306111Phase 2
- Risk Adapted Beacopp Regimen for Standard and High Risk Hodgkin LymphomaCompletedNCT00305149Not applicable
- Donor Umbilical Cord Blood Transplant in Treating Patients With Advanced Hematologic CancerCompletedNCT00304018Phase 1
- VNP40101M in Treating Patients With Richter Syndrome or Refractory or Relapsed Chronic Lymphocytic Leukemia or Other Lymphoproliferative DisordersCompletedNCT00304005Phase 1/2
- Radioimmunotherapy With 90Y-ibritumomab Tiuxetan as Part of a Dose Reduced Conditioning Regimen for Allogeneic Hematopoietic Cell Transplantation for the Treatment of Non-Hodgkin LymphomaCompletedNCT00302757Phase 1/2
- Low-Dose Fludarabine, Busulfan, and Anti-Thymocyte Globulin Followed By Donor Umbilical Cord Blood Transplant in Treating Patients With Advanced Hematologic CancerCompletedNCT00301951Phase 1
- Busulfan and Fludarabine Before Donor Stem Cell Transplant in Treating Patients With Hematologic CancerWithdrawnNCT00301912Phase 2
- Donor Stem Cell Transplant Followed By Donor White Blood Cell Infusions in Treating Young Patients With Hematologic CancerTerminatedNCT00301860Not applicable
- Rituximab and Oblimersen in Treating Patients With Stage II, Stage III, or Stage IV Follicular Non-Hodgkin's LymphomaTerminatedNCT00301795Phase 2
- A Retrospective Study of Toxicity and Outcome of High Dose Chemotherapy With Autologous Stem Cell Transplant in Patients With Hodgkin Lymphoma (HL).CompletedNCT00301314
- A Retrospective Review of Gemcitabine, Methylprednisolone Cisplatin (GEM-P) With or Without Rituximab in Patients With Relapsed/Refractory Diffuse Large B Cell Lymphoma (DLBCL)CompletedNCT00301301
- Open-Label Study to Assess the Effect of Omeprazole on the Pharmacokinetics of VELCADE in Patients With Either Advanced Solid Tumors or Non-Hodgkin's Lymphoma.CompletedNCT00298779Phase 1
- MDX-060 in Patients With Relapsed or Refractory Classic Systemic or Primary Cutaneous Anaplastic Large Cell LymphomaWithdrawnNCT00298467Phase 2
- Dual Time Point PET Imaging in LymphomaStatus unknownNCT00297557
- Donor Stem Cell Transplant in Treating Older or Frail Patients With Hematologic CancerCompletedNCT00296023Not applicable
- Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer, Metastatic Kidney Cancer, or Aplastic AnemiaStatus unknownNCT00295997Not applicable
- SL-11047 in Treating Patients With Relapsed or Refractory LymphomaCompletedNCT00293488Phase 1
- Methotrexate, Mannitol, Rituximab, and Carboplatin in Treating Patients With Newly Diagnosed Primary Central Nervous System LymphomaStatus unknownNCT00293475Phase 1/2
- 3-AP and Gemcitabine in Treating Patients With Advanced Solid Tumors or LymphomaCompletedNCT00293345Phase 1
- A Phase II Study of Nasal NK/T-cell LymphomaCompletedNCT00292695Phase 2
- Rituximab and Combination Chemotherapy in Treating Older Patients With Previously Untreated B-Cell LymphomaCompletedNCT00290667Phase 2
- Chemotherapy and Total-Body Irradiation Followed by Donor Umbilical Cord Blood Transplant, Cyclosporine, and Mycophenolate Mofetil in Treating Patients With Hematologic CancerCompletedNCT00290641Not applicable
- Donor Umbilical Cord Blood Transplant in Treating Patients With Hematologic CancerTerminatedNCT00290628Not applicable
- Study of Weekly Motexafin Gadolinium (MGd) for Patients With Chronic Lymphocytic Leukemia or Small Lymphocytic LymphomaCompletedNCT00290004Phase 1/2
- Early On-therapy PET at First-line Treatment in Diffuse Large B-cell Lymphoma Stage IIB-IVCompletedNCT00286832
- Study of hA20 (Humanized Anti-CD20) in Patients With CD20+ Non-Hodgkin's LymphomaCompletedNCT00285428Phase 1/2
- Treatment of Mantle Cell Lymphoma at Diagnosis for Patients Under 65 YearsCompletedNCT00285389Phase 2
- Cytomegalovirus (CMV) Vaccine in Donors and Recipients Undergoing Allogeneic Hematopoietic Cell Transplant (HCT)CompletedNCT00285259Phase 2
- Feasibility and Efficacy of BACOPP-21 for Patients > 60 Years With Intermediate or Advanced Hodgkins LymphomaCompletedNCT00284271Phase 2
- Association of L-asparaginase-Methotrexate-Dexamethasone for Nasal and Nasal-type Natural Killer (NK)-T-cell LymphomaCompletedNCT00283985Phase 2
- Caregiver Support in the Coping of Patients Who Are Undergoing a Donor Bone Marrow TransplantCompletedNCT00281814
- Caregiver Support in the Quality of Life of Patients Who Are Undergoing Donor Bone Marrow TransplantationCompletedNCT00281801
- Rituximab in Combination With Outpatient Therapy for CD20+ LymphomaCompletedNCT00280878Phase 2
- Rituximab and Combination Chemotherapy in Treating Patients With Non-Hodgkin's LymphomaCompletedNCT00278421Phase 3
- Sorafenib in Treating Patients With Recurrent Non-Hodgkin's LymphomaCompletedNCT00278382Phase 2
- Pemetrexed Disodium in Treating Patients With Recurrent Malignant Gliomas, Primary CNS Lymphoma, or Brain MetastasesStatus unknownNCT00276783Phase 2
- Interferon Alfa in Treating Patients With Stage IV Solid Tumors, Lymphoma, or MyelomaCompletedNCT00276536Phase 1
- INST Phase II Trial of Gemcitabine and Irinotecan in Patients With Relapsed or Refractory Lymphoma.CompletedNCT00276003Phase 2
- Phase II Safety and Efficacy Study of Single-agent AT-101 in Patients With Relapsed or Refractory B-cell MalignanciesCompletedNCT00275431Phase 2
- Prednisolone or Dexamethasone Combined With Chemotherapy in Treating Young Patients With Newly Diagnosed Lymphoblastic LymphomaTerminatedNCT00275106Phase 3
- Temsirolimus in Treating Patients With Metastatic Solid Tumor or Lymphoma That Cannot Be Removed By Surgery Who Have Different Levels of Liver FunctionCompletedNCT00275093Phase 1
- Vorinostat and Decitabine in Treating Patients With Advanced Solid Tumors or Relapsed or Refractory Non-Hodgkin's Lymphoma, Acute Myeloid Leukemia, Acute Lymphocytic Leukemia, or Chronic Myelogenous LeukemiaCompletedNCT00275080Phase 1
- VP and G-CSF With or Without Rituximab in Autologous Peripheral Stem Cell Transplant For NHLCompletedNCT00274794Not applicable
- Trial of AVN-944 in Patients With Advanced Hematologic MalignanciesCompletedNCT00273936Phase 1
- External Beam Radiotherapy and Zevalin for Management of Indolent B-Cell Non-Hodgkin's LymphomaCompletedNCT00271050Phase 1
- A Pathology Reference Laboratory for the Study of Infectious Diseases and Malignant LymphomaStatus unknownNCT00266370
- Bortezomib and Rituximab in Treating Patients With Relapsed or Refractory B-Cell Non-Hodgkin's LymphomaTerminatedNCT00265928Phase 2
- Laboratory-Treated Donor Bone Marrow in Treating Patients Who Are Undergoing a Donor Bone Marrow Transplant for Hematologic CancerCompletedNCT00265837Phase 3
- A Comparative Study for Non-Hodgkin's Lymphoma in Hepatitis B Virus CarriersCompletedNCT00262210Phase 2
- Bortezomib, Rituximab and Dexamethasone (BORID) for Relapsed/Refractory Mantle Cell LymphomaStatus unknownNCT00261612Phase 2
- Rituximab, Vaccine Therapy, and GM-CSF in Treating Patients With Non-Hodgkin's LymphomaStatus unknownNCT00258336Phase 2
- Early Evaluation of the Response of Large B Cell Non Hodgkin's Lymphoma to Chemotherapy by PET/CTCompletedNCT00256490Not applicable
- Epoetin Alfa in Treating Patients With Anemia Who Are Undergoing Chemotherapy for CancerCompletedNCT00255749Phase 2
- Cyclophosphamide and/or Mycophenolate Mofetil With or Without Tacrolimus in Treating Patients Who Are Undergoing a Donor Bone Marrow or Peripheral Stem Cell Transplant for Hematologic CancerCompletedNCT00255710Phase 1
- G-CSF-Treated Donor Bone Marrow Transplant in Treating Patients With Hematologic DisordersTerminatedNCT00253552Not applicable
- Study of Dynavax's 1018 ISS, Following Rituxan in Patients With B-Cell Follicular LymphomaCompletedNCT00251394Phase 2
- Trial of Outpatient Immunotherapy With Rituximab and Aldesleukin (IL-2) vs. Rituximab Alone for Non-Hodgkin's LymphomaTerminatedNCT00250861Phase 2
- Donor White Blood Cell Infusions and Interleukin-2 in Treating Patients Who Are Undergoing an Autologous Stem Cell Transplant for Relapsed Advanced Lymphoid CancerCompletedNCT00248430Phase 1/2
- Combination Chemotherapy Followed By Autologous Stem Cell Transplant, and White Blood Cell Infusions in Treating Patients With Non-Hodgkin's LymphomaCompletedNCT00244946Phase 1
- Investigation of Safety, Tolerability and Maximum Tolerated Dose (MTD) of BI 2536 in Patients With Recurrent Advanced Aggressive Non-Hodgkin's Lymphoma (NHL)CompletedNCT00243087Phase 1
- Rituximab, Cyclophosphamide, and G-CSF Followed By Combination Chemotherapy in Treating Patients Who Are Undergoing Autologous Stem Cell Transplant Followed By Rituximab and GM-CSF for Refractory Diffuse Large B-Cell LymphomaCompletedNCT00242996Phase 2
- Patients With Low-Grade Non-Hodgkin's Lymphoma Previously Treated With Tositumomab and/or Iodine I 131 TositumomabCompletedNCT00240591
- Patients With Low-Grade Non-Hodgkin's Lymphoma Previously Treated With Iodine I 131 TositumomabCompletedNCT00240578
- Tositumomab And Iodine I 131-Tositumomab In Patients With Relapsed Indolent Non-Hodgkin's LymphomaCompletedNCT00240565Phase 2
- Fludeoxyglucose F 18 Positron Emission Tomography in Predicting Risk of Relapse in Patients With Non-Hodgkin's Lymphoma Who Are Undergoing Combination Chemotherapy With or Without Autologous Stem Cell or Bone Marrow TransplantCompletedNCT00238368Phase 2
- Doxorubicin Hydrochloride Liposome and Bortezomib in Treating Patients With Refractory Hematologic Cancer or Malignant Solid Tumor or Metastatic Breast CancerCompletedNCT00237627Phase 1/2
- A Study of Peripheral Blood Progenitor Cells Mobilisation (PBPC) With VTP195183 Plus Granulocyte-Colony Stimulating Factor (G-CSF) Compared to Mobilisation With G-CSF AloneCompletedNCT00234169Phase 1/2
- Gemcitabine in Treating Patients With Newly Diagnosed, Relapsed, or Chemotherapy-Resistant Mantle Cell LymphomaCompletedNCT00234026Phase 2
- Reproducibility of an Immobilization Device (BodyFIX) - Hodgkins/LymphomaCompletedNCT00232440Phase 1/2
- Study of Rasburicase as Treatment or Prevention of Hyperuricemia Associated With Tumor Lysis Syndrome in Patients With Relapsed or Refractory Lymphoma, Leukemia, or Solid Tumor MalignancyCompletedNCT00230217Phase 4
- Rituximab in Treating Patients With Follicular Non-Hodgkin's LymphomaCompletedNCT00227695Phase 3
- Evaluation of Brain Lesions in HIV-infected Patients for Diagnosis of Primary Central Nervous System LymphomaCompletedNCT00226304
- The RATIO: Registry of Infections and Lymphoma in Patients Treated With TNF-a AntagonistsStatus unknownNCT00224562
- A Safety Study of Rituximab Plus MTX Injected Into the Cerebrospinal Fluid in the Treatment of Brain LymphomaCompletedNCT00221325Phase 1
- Photopheresis as an Interventional Therapy for the Treatment of CTCL (Cutaneous T-Cell Lymphoma, Mycosis Fungoides) Stage 1A, 1B, 2ACompletedNCT00221039Phase 4
- Study for Evaluation of Efficacy and Safety of SH L 749 to Indolent B-cell Non-Hodgkin's LymphomaCompletedNCT00220285Phase 2
- Bortezomib and Antiviral Therapy Followed By Effusion Drainage, Bevacizumab, and Combination Chemotherapy in Treating Patients With Primary Effusion LymphomaCompletedNCT00217503Phase 2
- Vorinostat With or Without Isotretinoin in Treating Young Patients With Recurrent or Refractory Solid Tumors, Lymphoma, or LeukemiaCompletedNCT00217412Phase 1
- Rituximab and Gemcitabine for Patients With Relapsed or Refractory Diffuse Large B-Cell LymphomaTerminatedNCT00216164Phase 2